These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 18342887)

  • 21. Crystal structure of the BMP-2-BRIA ectodomain complex.
    Kirsch T; Sebald W; Dreyer MK
    Nat Struct Biol; 2000 Jun; 7(6):492-6. PubMed ID: 10881198
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Virtual screening and selection of drug-like compounds to block noggin interaction with bone morphogenetic proteins.
    Ahmed S; Metpally RP; Sangadala S; Reddy BV
    J Mol Graph Model; 2010 Apr; 28(7):670-82. PubMed ID: 20137990
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The pro-form of BMP-2 interferes with BMP-2 signalling by competing with BMP-2 for IA receptor binding.
    Hauburger A; von Einem S; Schwaerzer GK; Buttstedt A; Zebisch M; Schräml M; Hortschansky P; Knaus P; Schwarz E
    FEBS J; 2009 Nov; 276(21):6386-98. PubMed ID: 19804412
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structure of the Alk1 extracellular domain and characterization of its bone morphogenetic protein (BMP) binding properties.
    Mahlawat P; Ilangovan U; Biswas T; Sun LZ; Hinck AP
    Biochemistry; 2012 Aug; 51(32):6328-41. PubMed ID: 22799562
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatocyte growth factor up-regulates the expression of the bone morphogenetic protein (BMP) receptors, BMPR-IB and BMPR-II, in human prostate cancer cells.
    Ye L; Lewis-Russell JM; Davies G; Sanders AJ; Kynaston H; Jiang WG
    Int J Oncol; 2007 Feb; 30(2):521-9. PubMed ID: 17203235
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Identification of receptors for bone morphogenetic proteins].
    Nishitoh H
    Kokubyo Gakkai Zasshi; 1997 Mar; 64(1):24-37. PubMed ID: 9125848
    [TBL] [Abstract][Full Text] [Related]  

  • 27. N-linked glycosylation of the bone morphogenetic protein receptor type 2 (BMPR2) enhances ligand binding.
    Lowery JW; Amich JM; Andonian A; Rosen V
    Cell Mol Life Sci; 2014 Aug; 71(16):3165-72. PubMed ID: 24337809
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Model structures of the N-methyl-D-aspartate receptor subunit NR1 explain the molecular recognition of agonist and antagonist ligands.
    Moretti L; Pentikäinen OT; Settimo L; Johnson MS
    J Struct Biol; 2004 Mar; 145(3):205-15. PubMed ID: 14960371
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of the second and third extracellular loops of the adenosine A1 receptor in activation and allosteric modulation.
    Peeters MC; Wisse LE; Dinaj A; Vroling B; Vriend G; Ijzerman AP
    Biochem Pharmacol; 2012 Jul; 84(1):76-87. PubMed ID: 22449615
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mutagenesis study of rice nonspecific lipid transfer protein 2 reveals residues that contribute to structure and ligand binding.
    Cheng CS; Chen MN; Lai YT; Chen T; Lin KF; Liu YJ; Lyu PC
    Proteins; 2008 Feb; 70(3):695-706. PubMed ID: 17729272
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Crystal structure analysis reveals how the Chordin family member crossveinless 2 blocks BMP-2 receptor binding.
    Zhang JL; Qiu LY; Kotzsch A; Weidauer S; Patterson L; Hammerschmidt M; Sebald W; Mueller TD
    Dev Cell; 2008 May; 14(5):739-50. PubMed ID: 18477456
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bone morphogenetic proteins and their receptors: potential functions in the brain.
    Ebendal T; Bengtsson H; Söderström S
    J Neurosci Res; 1998 Jan; 51(2):139-46. PubMed ID: 9469567
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bone morphogenetic proteins and growth and differentiation factors in the human cornea.
    You L; Kruse FE; Pohl J; Völcker HE
    Invest Ophthalmol Vis Sci; 1999 Feb; 40(2):296-311. PubMed ID: 9950587
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Type I receptor binding of bone morphogenetic protein 6 is dependent on N-glycosylation of the ligand.
    Saremba S; Nickel J; Seher A; Kotzsch A; Sebald W; Mueller TD
    FEBS J; 2008 Jan; 275(1):172-83. PubMed ID: 18070108
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High-throughput measurements of bone morphogenetic protein/bone morphogenetic protein receptor interactions using biolayer interferometry.
    Khodr V; Machillot P; Migliorini E; Reiser JB; Picart C
    Biointerphases; 2021 Jun; 16(3):031001. PubMed ID: 34241280
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structure of the ternary signaling complex of a TGF-beta superfamily member.
    Allendorph GP; Vale WW; Choe S
    Proc Natl Acad Sci U S A; 2006 May; 103(20):7643-8. PubMed ID: 16672363
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression and regulation of type I BMP receptors during early avian sympathetic ganglion development.
    McPherson CE; Varley JE; Maxwell GD
    Dev Biol; 2000 May; 221(1):220-32. PubMed ID: 10772803
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Bone morphogenetic protein (BMP) receptors and signal transduction].
    Yamashita H; Miyazono K
    Nihon Rinsho; 1999 Jan; 57(1):220-6. PubMed ID: 10036966
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Deletion mutants of BMP folding variants act as BMP antagonists and are efficient inhibitors for heterotopic ossification.
    Weber FE; Schmökel H; Oelgeschläger M; Nickel J; Maly FE; Hortschansky P; Grätz KW
    J Bone Miner Res; 2003 Dec; 18(12):2142-51. PubMed ID: 14672349
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structure-function relationship of inhibitory Smads: Structural flexibility contributes to functional divergence.
    Hariharan R; Pillai MR
    Proteins; 2008 Jun; 71(4):1853-62. PubMed ID: 18175316
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.